Company Financials

Cathay Biotech, Inc. Financials

Renminbi

business Cathay Biotech, Inc. Company Profile

Main Stock Listing

SSE: 688065

Market Capitalization CN¥36.66 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 54.13
Forward PE 41.16
Price to Sales TTM CN¥10.93
Price to Book MRQ CN¥1.99
Enterprise to Revenue 9.12
Enterprise to EBITDA 35.43

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 18.08%
Operating Margin 29.94%
Return on Assets TTM 1.52%
Return on Equity TTM 3.09%

Income Statement

Revenue TTM CN¥3,287,868,928
Revenue per Share TTM CN¥5.08
Quarterly Revenue Growth 13.40%
Gross Profit TTM CN¥1,007,726,080
EBITDA CN¥747,763,286
Net Income to Common TTM CN¥594,458,304
Diluted EPS TTM CN¥0.92
Quarterly Earnings Growth YoY 45.30%

Balance Sheet

Total Cash MRQ CN¥9,008,243,712
Total Cash per Share MRQ CN¥12.79
Total Debt MRQ CN¥
Total Debt to Equity MRQ 1.32
Current Ratio MRQ 6.94
Book Value per Share MRQ CN¥24.98

Cash Flow

Operating Cash Flow TTM CN¥418,006,592
Levered Free Cash Flow TTM CN¥-498,985,600

688065 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 721,289,794
Float Shares 255,249,064
Avg 10 Volume 2,639,440
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 66.83%
% Held by Institutions 6.04%

Stock Price Summary

Beta 0.57
Fifty Two Week Low CN¥36.81
Fifty Two Week High CN¥56.16
Fifty Two Week Change 21.87%
Day 50 MA CN¥48.55
Day 200 MA CN¥49.55

Dividends and Splits

Forward Annual Dividend Rate CN¥1.60
Forward Annual Dividend Yield 3.21%
Trailing Annual Dividend Rate CN¥0.40
Trailing Annual Dividend Yield 0.80%
Payout Ratio 43.48%
Dividend Date
Ex Dividend Date 2025-08-01
Last Split Factor
Last Split Date 2022-07-20